HIV Clinical Pharmacist Services
Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
Using a multidisciplinary approach to harness the electronic patient portal for completion of RWHAP six-month recertification documents, we were able to create a more patient-centered method that complies with program requirements. We will discuss the challenges, opportunities, and results of using such technology in program recertification.
Resource (Conference Presentation) updated 09/14/2023
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 03/19/2024
Resource updated 03/13/2024
Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,
Resource updated 09/20/2023
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023
Healthcare providers can receive no-cost expert clinical consultation in HIV prevention & care, HCV treatment, and substance use management.
Resource updated 09/20/2023
Tools used for quality and program monitoring by a Part A program.
Resource updated 09/19/2023
Federal guidelines for treatment, prevention and care of HIV disease, opportunistic infections, and common co-infections.
Resource updated 09/19/2023
Tool for service and program monitoring.
Resource updated 09/19/2023
CPAPA is no longer being updated by NASTAD and has been replaced by Pharmaceutical Company Patient Assistance Programs and Cost-Sharing Assistance Programs.
Resource updated 10/31/2023
Learn about World AIDS Day and activities of HRSA's Ryan White HIV/AIDS Program.
Blog updated 11/09/2023
Pre-application webinars for Notice of Funding Opportunity (NOFO) announcements from HRSA's HIV/AIDS Bureau for the Ryan White HIV/AIDS Program (RWHAP).
Resource updated 03/07/2024
Summary of pre-exposure prophylaxis (PrEP) provisions under HRSA and the Ryan White HIV/AIDS Program and PrEP resources on coverage and costs and providers with PrEP expertise.
Blog updated 11/14/2023
Tools to assist ADAPs with benefits management activities to help clients obtain and maintain access to private and public insurance.
Resource updated 09/14/2023